NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
11/08/2021
Back to search
Official data from USPTO
SELECT DRUG PROGRAM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SELECT DRUG PROGRAM
ST13
US500000075421213Class
36
Filing
75421213
Registration
2464140
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
11/08/2021
Trademark type
Word
Nice classes
36
Filing date
01/21/1998
Registration date
06/26/2001
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/08/2021
Last transaction
11/08/2021
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
1997-11-00
First use in commerce
1997-11-00
Drawing code
1
Owner type
16
Owner location
Philadelphia, PA, US
Examiner
BILLINGS, JESSIE W
Law office
L30
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Independence Blue Cross, LLC
I. C. (pessoa física)
Representatives
Gene K. Park MORGAN LEWIS & BOCKIUS LLP
Technical classification
Nice Classes
Class 36
Vienna Codes
No Vienna codes available.
Goods and services
Class 36
Prescription drug insurance underwriting and administration services
Publications
History of USPTO decisions and trademark events.
30 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
11/08/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/08/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/05/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
06/23/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/26/2020
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
07/09/2014
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
07/11/2011
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/11/2011
E89R
TEAS SECTION 8 & 9 RECEIVED
06/23/2011
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/02/2007
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
09/24/2007
E815
TEAS SECTION 8 & 15 RECEIVED
09/24/2007
CFIT
CASE FILE IN TICRS
10/11/2006
R.PR
REGISTERED-PRINCIPAL REGISTER
06/26/2001
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/06/2001
DOCK
ASSIGNED TO EXAMINER
03/05/2001
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/28/2001
EX2G
SOU EXTENSION 2 GRANTED
02/26/2001
IUAF
USE AMENDMENT FILED
01/11/2001
EXT2
SOU EXTENSION 2 FILED
01/11/2001
EX1G
SOU EXTENSION 1 GRANTED
08/30/2000
EXT1
SOU EXTENSION 1 FILED
07/11/2000
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
01/11/2000
PUBO
PUBLISHED FOR OPPOSITION
10/19/1999
NPUB
NOTICE OF PUBLICATION
09/17/1999
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/27/1999
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/28/1999
CNRT
NON-FINAL ACTION MAILED
10/29/1998
DOCK
ASSIGNED TO EXAMINER
10/15/1998
Continuous trademark protection
Get notified about every new filing that threatens SELECT DRUG PROGRAM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.